Export 14 results:
Author Title Type [ Year(Asc)]
Filters: Author is Balasubramanian, Poonkuzhali  [Clear All Filters]
2023
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines.. Leuk Res. 128:107054. DOI:10.1016/j.leukres.2023.107054.
Illangeswaran RStephen St, Jebanesan DZechariah, Sivakumar KKanimozhi, Vidhyadharan RThalayattu, Rajamani BM, Janet NBeryl, David E, Velayudhan SRamachandr, Mathews V, Balasubramanian P.  2023.  Corrigendum to "Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines" [Leukemia Res. 128, 107054].. Leuk Res. 130:107329. DOI:10.1016/j.leukres.2023.107329.
Venkatesan V, Christopher ACrystal, Rhiel M, Azhagiri MKumar K, Babu P, Walavalkar K, Saravanan B, Andrieux G, Rangaraj S, Srinivasan S, Karuppusamy KV, Jacob A, Bagchi A, Pai AAnand, Nakamura Y, Kurita R, Balasubramanian P, Pai R, Marepally SKumar, Mohankumar KMurugesan et al..  2023.  Editing the core region in HPFH deletions alters fetal and adult globin expression for treatment of β-hemoglobinopathies.. Mol Ther Nucleic Acids. 32:671-688. DOI:10.1016/j.omtn.2023.04.024.
Ijee S, Chambayil K, Chaudhury ADutta, Bagchi A, Modak K, Das S, Benjamin ESathya Bam, Rani S, Paul DZechariah, Nath A, Roy D, Palani D, Priyanka S, Ravichandran R, Kumary BK, Sivamani Y, S V, Babu D, Nakamura Y, Thamodaran V et al..  2023.  Efficient deletion of microRNAs using CRISPR/Cas9 with dual guide RNAs.. Front Mol Biosci. 10:1295507. DOI:10.3389/fmolb.2023.1295507.
Balakrishnan B, Illangeswaran RStephen St, Rajamani BMurugan, Arunachalam AKumar, Pai AAnand, Mohanan E, Srivastava A, Mathews V, Balasubramanian P.  2023.  Metformin pretreatment ameliorates busulfan-induced liver endothelial toxicity during haematopoietic stem cell transplantation.. PLoS One. 18(10):e0293311. DOI:10.1371/journal.pone.0293311.
Rajamani BM, Illangeswaran RStephen St, Benjamin ESathya Bam, Balakrishnan B, Jebanesan DZechariah, Das S, Pai AAnand, Vidhyadharan RThalayattu, Mohan A, Karathedath S, Abraham A, Mathews V, Velayudhan SR, Balasubramanian P.  2023.  Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib and reduces disease burden .. Front Pharmacol. 14:1187066. DOI:10.3389/fphar.2023.1187066.